Eisai Sues Mylan Over Aciphex ANDA
Japanese pharmaceutical company Eisai has filed a lawsuit in the U.S. District Court for the Southern District of New York against generics maker Mylan Laboratories over its abbreviated new drug application...To view the full article, register now.
Already a subscriber? Click here to view full article